UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $1.68M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
1
Closed
3
Calls
$300K
Puts
$6K
Net Calls
+$294K
Net Calls Change
+$676K
Name Holding Trade Value Shares
Change
Shares
Change %
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$801K +$801K +40,030 New
Jane Street
2
Jane Street
New York
$321K +$44.4K +2,216 +16%
TRCT
3
Tower Research Capital (TRC)
New York
$290K +$146K +7,293 +101%
VF
4
Virtu Financial
New York
$240K -$195K -9,743 -45%
Morgan Stanley
5
Morgan Stanley
New York
$16K
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$14K
Simplex Trading
7
Simplex Trading
Illinois
$2K +$2K +135 New
UBS Group
8
UBS Group
Switzerland
-$144K -3,269 Closed
PNC Financial Services Group
9
PNC Financial Services Group
Pennsylvania
-$44K -1,000 Closed
AIM
10
Anchor Investment Management
South Carolina
-$12.2K -275 Closed